GLP-1 Combination Therapy May Unlock New Benefits for Psoriasis Patients
The Hill reports GLP-1 combination therapy may unlock new psoriasis benefits — a promising signal, but one awaiting controlled trial data before it changes practice.
Topic
Topic
The Hill reports GLP-1 combination therapy may unlock new psoriasis benefits — a promising signal, but one awaiting controlled trial data before it changes practice.
GLP-1 combination therapy may bring added benefits to psoriasis patients, The Hill reports, though no trial design, cohort, or PA…
Lilly reports Zepbound (tirzepatide) enhanced Taltz (ixekizumab) efficacy in a psoriasis study, a signal for combination therapy…
Eli Lilly says a psoriasis study found Taltz plus Zepbound outperformed Taltz monotherapy; full efficacy and safety data are stil…
Expert guidance from HCPlive focuses on optimizing HS biologics, combination therapy and surgical timing in hidradenitis suppurat…
NewsNation reports GLP-1 combination therapy may unlock new benefits for psoriasis patients, extending the metabolic-skin overlap…
A new global consensus on integrated skin care sets out shared principles for sequencing medical, device and aesthetic therapies…